Cefmetazole Sodium

CHEMBL1201118 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
493.5 g/mol
LogP
Phase
4

The sodium salt preparation of cefmetazole, administered intravenously for polymicrobial and anaerobic-inclusive infections such as intra-abdominal sepsis. It provides cephamycin-class antibacterial coverage with good anaerobic activity. Monitoring of coagulation parameters may be advisable with prolonged use.

Moleküler Ağırlık

493,5000 g/mol

TPSA

242,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+]

InChI

InChI=1S/C15H17N7O5S3.Na/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25;/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25);/q;+1/p-1/t13-,15+;/m1./s1

Molecular Formula

C15H16N7NaO5S3

HBD / HBA

1 / 12

Döndürülebilir Bağlar

9

Ağır Atomlar

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The sodium salt preparation of cefmetazole, administered intravenously for polymicrobial and anaerobic-inclusive infections such as intra-abdominal sepsis. It provides cephamycin-class antibacterial coverage with good anaerobic activity. Monitoring of coagulation parameters may be advisable with prolonged use.

Yes, Cefmetazole Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201118. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23666711. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.